Traders Daily — This Can’t Remain this Oversold


Let’s start the week with another winner.

Just weeks ago, we recommended buying shares of Facebook (FB) at $158.25.

After an earnings beat, the stock is now up to $173.60.  Take the win here, as the stock appears to be technically overbought.

As for new opportunities, take a look at Bristol Myers (BMY).

The stock plummeted on news that a rival cancer drug could perform better than the one it’s been working on. But what BMY has is just as incredible.  Its Opdivo drug was found to redu...

Register Now

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Already a member? Login below, or click here to register now for free.